Status:
COMPLETED
Left Ventricular Mass Index Predicts Clinical Outcomes in Patients with Obstructive Hypertrophic Cardiomyopathy Undergoing Septal Myectomy
Lead Sponsor:
Changrong Nie
Conditions:
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Eligibility:
All Genders
18+ years
Brief Summary
In this study, we aimed to analyze the association between left ventricular mass index and clinical outcomes to provide the potential indicator for worse survival.
Detailed Description
This retrospective study aimed to determine the prognostic value of left ventricular mass index in predicting clinical outcomes, including all-cause death, new-onset or recurrent atrial fibrillation, ...
Eligibility Criteria
Inclusion
- (1) Difficulty in relieving symptoms with medication or recurrent syncope. (2) Left ventricular outflow tract (LVOT) pressure gradient ≥ 50 mmHg at rest or with provocation and the maximum thickness of the septum is ≧ 15 mm.
Exclusion
- (1) Combined right ventricular outflow tract obstruction requiring right ventricular outflow tract dissection. (2) Combined mitral or aortic valve organic lesions requiring valve replacement surgery. (3) Apical ventricular aneurysm formation requiring ventriculotomy. (4) Previous septal reduction therapy, including alcohol ablation or septal myectomy. (5) patients did not undergo cardiac magnetic resonance examination.
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
490 Patients enrolled
Trial Details
Trial ID
NCT06609382
Start Date
June 1 2011
End Date
December 31 2020
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai hospital
Beijing, Beijing Municipality, China, 100037